Latest Board Appointments News

Page 11 of 29
TZ Limited appoints Antonino Schiavello as Non-Executive Director and partners with his Nura Space venture to accelerate workplace technology solutions, while securing a $750,000 credit extension to support product delivery.
Sophie Babbage
Sophie Babbage
12 Sept 2025
Metal Bank Limited has agreed to acquire Hastings Technology Metals’ Western Australian gold assets, expanding its portfolio and advancing key projects toward production.
Maxwell Dee
Maxwell Dee
10 Sept 2025
Adelong Gold has locked in a $1.25 million strategic investment from Nova Minerals and Barclay Wells clients, enabling accelerated exploration at its NSW and Victorian gold-antimony projects.
Maxwell Dee
Maxwell Dee
9 Sept 2025
Adelong Gold has locked in a $1.25 million strategic investment from Nova Minerals and Barclay Wells clients, enabling accelerated exploration at its NSW and Victorian gold and antimony projects. This partnership includes board representation and offtake rights, positioning Adelong for growth in proven mineral corridors.
Maxwell Dee
Maxwell Dee
9 Sept 2025
Theta Gold Mines appoints Hansjoerg Plaggemars as non-executive director and promotes Bill Richie Yang to executive director, bolstering financial and project development leadership as the TGME Gold Mine Project advances.
Maxwell Dee
Maxwell Dee
8 Sept 2025
Green360 Technologies announces CEO Bojan Bogunovic's resignation effective October 31, with Executive Chairman Aaron Banks stepping in to lead daily operations during a pivotal growth phase.
Victor Sage
Victor Sage
4 Sept 2025
My Foodie Box Limited is set to pivot from meal kits to mining by acquiring Australian gold, copper, and rare earth projects, renaming itself Tarrina Resources, and relisting on the ASX with a $5 million capital raise.
Maxwell Dee
Maxwell Dee
1 Sept 2025
Holista Colltech reports a sharp 70% reduction in net loss and an 8.6% revenue rise, driven by strong supplements sales and a landmark collagen partnership with Regenerex Pharma.
Ada Torres
Ada Torres
29 Aug 2025
Cambium Bio reported a $3.84 million loss for FY25 but secured critical FDA approvals and ethics clearances to initiate Phase 3 trials of Elate Ocular®, supported by a $2.12 million capital raise.
Ada Torres
Ada Torres
29 Aug 2025
Firebrick Pharma reported a substantial increase in Nasodine Nasal Spray revenues in FY25, alongside a widening net loss driven by reduced R&D incentives and increased marketing investments. The company is advancing its international rollout with new licensing deals and board appointments.
Ada Torres
Ada Torres
29 Aug 2025
Cycliq Group Limited reported a 3.8% revenue increase to AUD 4.78 million for FY2025 alongside a significant reduction in net loss, driven by strategic product enhancements and a new AI partnership. The company also strengthened its board and launched a revamped e-commerce platform, positioning itself for growth despite ongoing legal and operational risks.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Linius Technologies reported a $5.31 million loss for FY25 as it shifts towards a sales-driven SaaS model, with new leadership and cost-cutting measures aiming to reshape its future.
Sophie Babbage
Sophie Babbage
29 Aug 2025